[HTML][HTML] DNA methylation signatures of youth-onset type 2 diabetes and exposure to maternal diabetes
OE Salama, N Hizon, M Del Vecchio, K Kolsun… - Clinical …, 2024 - Springer
Objective Youth-onset type 2 diabetes (T2D) is physiologically distinct from adult-onset, but it
is not clear how the two diseases differ at a molecular level. In utero exposure to maternal …
is not clear how the two diseases differ at a molecular level. In utero exposure to maternal …
[HTML][HTML] DNA methylation signatures of youth-onset type 2 diabetes and exposure to maternal diabetes
OE Salama, N Hizon… - Clinical …, 2024 - clinicalepigeneticsjournal …
Youth-onset type 2 diabetes (T2D) is physiologically distinct from adult-onset, but it is not
clear how the two diseases differ at a molecular level. In utero exposure to maternal type 2 …
clear how the two diseases differ at a molecular level. In utero exposure to maternal type 2 …
DNA methylation signatures of youth-onset type 2 diabetes and exposure to maternal diabetes
OE Salama, N Hizon, M Del Vecchio, K Kolsun… - 2024 - mspace.lib.umanitoba.ca
Objective Youth-onset type 2 diabetes (T2D) is physiologically distinct from adult-onset, but it
is not clear how the two diseases differ at a molecular level. In utero exposure to maternal …
is not clear how the two diseases differ at a molecular level. In utero exposure to maternal …
[HTML][HTML] DNA methylation signatures of youth-onset type 2 diabetes and exposure to maternal diabetes
OE Salama, N Hizon, M Del Vecchio, K Kolsun… - Clinical …, 2024 - ncbi.nlm.nih.gov
Objective Youth-onset type 2 diabetes (T2D) is physiologically distinct from adult-onset, but it
is not clear how the two diseases differ at a molecular level. In utero exposure to maternal …
is not clear how the two diseases differ at a molecular level. In utero exposure to maternal …
DNA methylation signatures of youth-onset type 2 diabetes and exposure to maternal diabetes.
OE Salama, N Hizon, M Del Vecchio, K Kolsun… - Clinical …, 2024 - europepmc.org
Objective Youth-onset type 2 diabetes (T2D) is physiologically distinct from adult-onset, but it
is not clear how the two diseases differ at a molecular level. In utero exposure to maternal …
is not clear how the two diseases differ at a molecular level. In utero exposure to maternal …
DNA methylation signatures of youth-onset type 2 diabetes and exposure to maternal diabetes.
OE Salama, N Hizon, M Del Vecchio… - Clinical …, 2024 - search.ebscohost.com
Objective: Youth-onset type 2 diabetes (T2D) is physiologically distinct from adult-onset, but
it is not clear how the two diseases differ at a molecular level. In utero exposure to maternal …
it is not clear how the two diseases differ at a molecular level. In utero exposure to maternal …
DNA methylation signatures of youth-onset type 2 diabetes and exposure to maternal diabetes
OE Salama, N Hizon, M Del Vecchio… - Clinical …, 2024 - pubmed.ncbi.nlm.nih.gov
Objective Youth-onset type 2 diabetes (T2D) is physiologically distinct from adult-onset, but it
is not clear how the two diseases differ at a molecular level. In utero exposure to maternal …
is not clear how the two diseases differ at a molecular level. In utero exposure to maternal …
[PDF][PDF] DNA methylation signatures of youth-onset type 2 diabetes and exposure to maternal diabetes
OE Salama, N Hizon, M Del Vecchio, K Kolsun… - 2024 - clinicalepigeneticsjournal …
Objective Youth-onset type 2 diabetes (T2D) is physiologically distinct from adult-onset, but it
is not clear how the two diseases differ at a molecular level. In utero exposure to maternal …
is not clear how the two diseases differ at a molecular level. In utero exposure to maternal …
[PDF][PDF] DNA methylation signatures of youth-onset type 2 diabetes and exposure to maternal diabetes
OE Salama, N Hizon, M Del Vecchio, K Kolsun… - 2024 - mspace.lib.umanitoba.ca
Objective Youth-onset type 2 diabetes (T2D) is physiologically distinct from adult-onset, but it
is not clear how the two diseases differ at a molecular level. In utero exposure to maternal …
is not clear how the two diseases differ at a molecular level. In utero exposure to maternal …